| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |